Onyx Pharmaceuticals

Portola Pharmaceuticals is a Bay Area–based pharmaceuticals company with a focus on bioresearch and drug development. Their efforts are directed towards global markets, specifically in the treatment of cardiovascular disease and inflammation. Generated from their available business information

Cytokinetics is a late-stage biopharmaceutical company based in South San Francisco, dedicated to developing innovative medicines that enhance muscle function and improve the lives of patients suffering from debilitating diseases, including cardiovascular and neuromuscular conditions. With over 25 years of experience, the company focuses on pioneering research in muscle biology, leveraging its robust pipeline of small molecule muscle activators and inhibitors. Generated from the website

Rigel Pharmaceuticals is a biotechnology company based in South San Francisco, CA, dedicated to the discovery, development, and provision of innovative therapies that significantly enhance the lives of patients with hematologic disorders and cancer. The company's pipeline includes proprietary programs such as IRAK1 and RIPK1, as well as partnered programs with leading pharmaceutical companies like BerGenBio, Daiichi-Sankyo, Grifols, Kissei Knight, Lilly, Medison, and Novo Nordisk. Rigel Pharmaceuticals is committed to developing novel treatments, including TAVALISSE for thrombocytopenia in adult patients with chronic immune thrombocytopenia and REZLIDHIA for adult patients with relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation.Generated from the website